Compounds > zalcitabine
Page last updated: 2024-08-22

zalcitabine and Lymphoma

zalcitabine has been researched along with Lymphoma in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (55.56)18.2507
2000's4 (44.44)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
French, JE; Karlsson, A; Rasmussen, A; Söderkvist, P; Ungerbäck, J1
Collins, BJ; Dunnick, JK; Elwell, MR; Heath, JE; Irwin, RD; Lindamood, C; Prejean, D; Rao, GN; Sanders, VM1
Cochran, C; Eklund, LK; Rao, GN; Söderkvist, P; Wiseman, RW; Zhuang, SM1
Moyle, GJ1
Clements, J; Clive, D; Elliott, BM; Green, M; Honma, M; Müller, L; San, RH; Shimada, H; Sofuni, T; Thybaud, V; Wilcox, P1
Haugen-Strano, A; Schippert, A; Söderkvist, P; Wiseman, RW; Zhuang, SM1
Söderkvist, P; Wiseman, RW; Zhuang, SM1
Söderkvist, P; Zhuang, S1
Karlsson, A; Söderkvist, P; Zhuang, SM1

Other Studies

9 other study(ies) available for zalcitabine and Lymphoma

ArticleYear
Notch1 is a frequent mutational target in chemically induced lymphoma in mouse.
    International journal of cancer, 2008, Dec-01, Volume: 123, Issue:11

    Topics: Amino Acid Sequence; Animals; Butadienes; Disease Models, Animal; Lymphoma; Mice; Molecular Sequence Data; Mutation; Receptor, Notch1; Sequence Alignment; Zalcitabine

2008
Induction of thymic lymphoma in mice administered the dideoxynucleoside ddC.
    Fundamental and applied toxicology : official journal of the Society of Toxicology, 1995, Volume: 27, Issue:2

    Topics: Animals; Antiviral Agents; Atrophy; Body Weight; Female; Intubation, Gastrointestinal; Lymphoma; Male; Mice; Mice, Inbred Strains; Organ Size; Thymus Gland; Thymus Neoplasms; Zalcitabine

1995
Allelotype analysis of 2',3'-dideoxycytidine- and 1,3-butadiene-induced lymphomas in B6C3F1 mice.
    Cancer research, 1996, Jul-15, Volume: 56, Issue:14

    Topics: Alleles; Animals; Butadienes; Chromosome Mapping; DNA, Neoplasm; Genes, Tumor Suppressor; Genetic Markers; Heterozygote; Lymphoma; Mice; Mice, Inbred Strains; Polymorphism, Single-Stranded Conformational; Sequence Deletion; Zalcitabine

1996
Occurrence of lymphomas during ddC or ddC/zidovudine combination therapy in persons infected with HIV type 1.
    Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1996, Dec-15, Volume: 13, Issue:5

    Topics: Antiviral Agents; HIV Infections; HIV-1; Humans; Lymphoma; Zalcitabine; Zidovudine

1996
Mouse lymphoma workshop: Victoria, British Columbia, Canada, March 27, 1996 protocol issues regarding the use of the Microwell Method of the Mouse Lymphoma Assay.
    Environmental and molecular mutagenesis, 1997, Volume: 29, Issue:4

    Topics: Adenosine; Animals; Cell Division; Chromosome Aberrations; Dose-Response Relationship, Drug; Lymphoma; Mice; Mutagenicity Tests; Mutation; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Software; Thymidine; Time Factors; Tumor Cells, Cultured; Zalcitabine

1997
Inactivations of p16INK4a-alpha, p16INK4a-beta and p15INK4b genes in 2',3'-dideoxycytidine- and 1,3-butadiene-induced murine lymphomas.
    Oncogene, 1998, Feb-12, Volume: 16, Issue:6

    Topics: Animals; Butadienes; Carcinogens; Carrier Proteins; Cell Cycle Proteins; CpG Islands; Cyclin-Dependent Kinase Inhibitor p15; Cyclin-Dependent Kinase Inhibitor p16; DNA Methylation; DNA, Neoplasm; Homozygote; Lymphoma; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Point Mutation; Polymorphism, Single-Stranded Conformational; Promoter Regions, Genetic; Sequence Analysis, DNA; Tumor Suppressor Proteins; Zalcitabine

1998
Mutation analysis of the pRb pathway in 2',3'-dideoxycytidine- and 1, 3-butadiene-induced mouse lymphomas.
    Cancer letters, 2000, May-01, Volume: 152, Issue:2

    Topics: Animals; Blotting, Southern; Butadienes; Carcinogens; Cyclin D1; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinases; DNA Mutational Analysis; Genes, Retinoblastoma; Lymphoma; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Polymorphism, Single-Stranded Conformational; Proto-Oncogene Proteins; Zalcitabine

2000
Genetic analysis of Raf1, Mdm2, c-Myc, Cdc25a and Cdc25b proto-oncogenes in 2',3'-dideoxycytidine- and 1,3-butadiene-induced lymphomas in B6C3F1 mice.
    Mutation research, 2000, Jul-20, Volume: 452, Issue:1

    Topics: Amino Acid Sequence; Animals; Base Sequence; Blotting, Southern; Butadienes; cdc25 Phosphatases; Cell Cycle Proteins; DNA Mutational Analysis; DNA, Neoplasm; Female; Gene Expression Regulation; Lymphoma; Male; Mice; Mice, Inbred AKR; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Inbred DBA; Mice, Inbred Strains; Molecular Sequence Data; Mutation; Nuclear Proteins; Polymorphism, Single-Stranded Conformational; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-raf; Proto-Oncogenes; Sequence Homology, Amino Acid; Sequence Homology, Nucleic Acid; Species Specificity; Zalcitabine

2000
Point mutations and deletions in the znfn1a1/ikaros gene in chemically induced murine lymphomas.
    Cancer research, 2002, May-01, Volume: 62, Issue:9

    Topics: Alleles; Animals; Blotting, Southern; Butadienes; Carcinogens; DNA-Binding Proteins; Gene Deletion; Gene Silencing; Ikaros Transcription Factor; Loss of Heterozygosity; Lymphoma; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Phenolphthalein; Point Mutation; Transcription Factors; Zalcitabine

2002